Literature DB >> 16488689

Phosphorylcholine coating may limit thrombin formation during high-risk cardiac surgery: a randomized controlled trial.

Federico Pappalardo1, Patrizia Della Valle, Giuseppe Crescenzi, Chiara Corno, Annalisa Franco, Lucia Torracca, Ottavio Alfieri, Laura Galli, Alberto Zangrillo, Armando D'Angelo.   

Abstract

BACKGROUND: During cardiopulmonary bypass, blood contact with the large nonendothelial surfaces of the extracorporeal circuit induces activation and consumption of platelets and plasma coagulation factors. Phosphorylcholine (Pc) coating of oxygenators has been designed to improve surface biocompatibility. We evaluated the effects of a Pc-coated oxygenator on blood coagulation in patients undergoing high-risk open heart surgery and receiving tranexamic acid.
METHODS: Thirty-nine patients undergoing reoperative valvular or combined procedures were randomized to the use of an oxygenator treated with Pc coating (Pc group) or of a standard oxygenator (control group). Platelet count, soluble CD40 ligand, fibrinogen, antithrombin, D-Dimer, prothrombin fragment 1.2 (F1.2), and free plasma hemoglobin levels were measured at baseline, at aortic unclamping, and at arrival in the intensive care unit.
RESULTS: Postoperative bleeding, need for blood products, and clinical outcomes were similar in the two groups. At unclamping, F1.2, a marker of in vivo thrombin formation, increased to a greater extent in control patients than in Pc patients (p = 0.02), and in the latter group of patients was positively correlated with aortic cross-clamp times (r = 0.70). Relative to baseline values, the percent decrease in platelet count, fibrinogen, and antithrombin levels was not significantly different in Pc patients and in control patients after adjustment for multiple comparisons, but the percent decrease in platelet counts was negatively correlated with F1.2 levels in the entire series of patients (r = -0.62, p < 0.0001). All the evaluated parameters were similar in the two groups of patients at arrival in the intensive care unit.
CONCLUSIONS: For patients undergoing high-risk open heart surgery and receiving tranexamic acid, a phosphorylcholine-coated oxygenator may reduce intraoperative thrombin formation and the associated consumption of platelets, fibrinogen, and antithrombin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16488689     DOI: 10.1016/j.athoracsur.2005.09.006

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  10 in total

1.  Retrospective analysis comparing hollow fiber and silicone membrane oxygenators for neonates on ECMO.

Authors:  Brian Mejak; Carmen Giacomuzzi; Eileen Heller; Xiaomang You; Ross Ungerleider; Irving Shen
Journal:  J Extra Corpor Technol       Date:  2007-06

2.  Impact of a phosphorylcholine-coated cardiac bypass circuit on blood loss and platelet function: a prospective, randomized study.

Authors:  Sandrine Marguerite; François Levy; Astrid Quessard; Jean-Pierre Dupeyron; Cécile Gros; Annick Steib
Journal:  J Extra Corpor Technol       Date:  2012-03

3.  Computational evaluation of the thrombogenic potential of a hollow-fiber oxygenator with integrated heat exchanger during extracorporeal circulation.

Authors:  Alessandra Pelosi; Jawaad Sheriff; Marco Stevanella; Gianfranco B Fiore; Danny Bluestein; Alberto Redaelli
Journal:  Biomech Model Mechanobiol       Date:  2012-10-06

Review 4.  VV extracorporeal life support for the Third Millennium: will we need anticoagulation?

Authors:  Danny Eytan; Yuval Bitterman; Gail M Annich
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

5.  Poly-2-methoxyethylacrylate-coated bypass circuits reduce activation of coagulation system and inflammatory response in congenital cardiac surgery.

Authors:  Yasuyuki Suzuki; Kazuyuki Daitoku; Masahito Minakawa; Kozo Fukui; Ikuo Fukuda
Journal:  J Artif Organs       Date:  2008-10-05       Impact factor: 1.731

6.  Humoral immune response and coated or uncoated oxygenators during cardiopulmonary bypass surgery.

Authors:  Sedat Ozan Karakisi; Ayşe Gül Kunt; Şahin Bozok; İdil Çankaya; Mustafa Kocakulak; Uğur Muşabak; Mustafa Fevzi Sargon; Şaban Ergene; Gökhan İlhan; Hakan Karamustafa; Nebiye Tufekci; Erol Şener
Journal:  Cardiovasc J Afr       Date:  2016 Jul/Aug       Impact factor: 1.167

Review 7.  Novel Surfaces in Extracorporeal Membrane Oxygenation Circuits.

Authors:  Andrea Ontaneda; Gail M Annich
Journal:  Front Med (Lausanne)       Date:  2018-11-20

Review 8.  Biomimetic materials based on zwitterionic polymers toward human-friendly medical devices.

Authors:  Kazuhiko Ishihara
Journal:  Sci Technol Adv Mater       Date:  2022-09-13       Impact factor: 7.821

Review 9.  Advances in extracorporeal membrane oxygenator design for artificial placenta technology.

Authors:  David G Blauvelt; Emily N Abada; Peter Oishi; Shuvo Roy
Journal:  Artif Organs       Date:  2020-11-04       Impact factor: 3.094

Review 10.  Hematologic concerns in extracorporeal membrane oxygenation.

Authors:  Jonathan Sniderman; Paul Monagle; Gail M Annich; Graeme MacLaren
Journal:  Res Pract Thromb Haemost       Date:  2020-05-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.